Resources

Colin G. Miller
Ph.D, FIPEM, CSci, has been a leader in the development of medical imaging in clinical trials. He has more than 30 years in medical and scientific consulting. He also provides strategic development for the regulatory pathway and FDA interaction with respect to new diagnostics and end points in therapeutic clinical development. He has over 70 peer reviewed publications, 3 patents and published three books including “Medical Imaging in Clinical Trials” by Springer.
Recent Posts

Are Placebo-Controlled Trials in Osteoporosis Ethical?

Colin G. Miller

The Use of Biomakers and PET in Early Alzheimer's Disease Diagnosis

Colin G. Miller

How Time, Quality, & Cost Metrics Affect Clinical Trials and Programs

Colin G. Miller

EOS Imaging System is an Emerging New Technology

Colin G. Miller

Five Things Every Data Manager Should Know When It Comes to Medical Images in Clinical Trials

Colin G. Miller

Monitoring Skeletal Integrity for Safer Diabetes Therapies

Colin G. Miller

Five Documents Critical for the Success of Clinical Trials with Medical Images

Colin G. Miller

The Bracken Group Responds to the FDA New Draft Guideline on Clinical Trial Compliance Proposing Novel Technology from Bracken Data

Colin G. Miller
CONTACT US

Ask us anything.

We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.